Ameen Alizada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ameen Alizada has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Al-Ani
Section of Ophthalmology, Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, Canada
2 shared publications - Kareem Sadek
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
2 shared publications - Salem Abu Al-Burak
Schulich School of Medicine & Dentistry, Western University, London, ON, Canada
2 shared publications Abdelwahab Aleshawi
1 shared publication- Ahmed Abdel-Sayyed
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
1 shared publication Benjamin Agnelli
University of Calgary
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- p. 1-9
In-Hospital Stroke in Patients with Cardiac Conditions: Do Cardiac Procedures Impact Stroke Outcomes?
Background and aims: It is unclear if stroke occurring after cardiac procedures is more severe than stroke associated with cardiac conditions without procedures. We compared in-hospital acute ischemic stroke patients admitted with a cardiac diagnosis who did versus did not undergo cardiac procedures. Methods: In this retrospective cohort study, we analyzed adults with in-hospital stroke admitted with a primary cardiac diagnosis in Alberta (2018–2022). Patients were categorized into no prior cardiac procedure, cardiac procedure, or cardiac surgery within 30 days of stroke diagnosis. Multivariable logistic regression was used to assess associations between exposure groups and outcomes. Results: Among 499 patients (median age 70 years IQR [62–77], 36.7% women), 116 (23.2%) underwent a cardiac procedure, and 227 (45.5%) underwent cardiac surgery prior to stroke diagnosis. Median time from procedure to stroke diagnosis was 1.75 days (IQR 0.87–3.83). In-hospital mortality was 34.6%, 24.1% and 22.5% in patients with no prior procedure, cardiac procedures and cardiac surgery, respectively. After adjustment for age, sex, facility level and comorbidities, no significant differences were observed in mortality (cardiac procedure vs no procedure: aOR 0.73, 95% confidence interval (CI) 0.40–1.33; cardiac surgery vs no procedure: aOR 0.78, 95% CI 0.42–1.45). Among procedural patients, strokes recognized ≥2 days post-procedure were associated with higher mortality (2–7 days: OR 2.31, [1.18–4.52]; 8–30 days: OR 3.23, [1.59–6.59]). Conclusions: Adjusted mortality did not differ by cardiac procedural status, although residual confounding is possible. Later stroke recognition after cardiac procedures was associated with higher mortality, identifying a high-risk monitoring window.
- 5 November 2026
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- p. 1-9
Open AccessIn-Hospital Stroke in Patients with Cardiac Conditions: Do Cardiac Procedures Impact Stroke Outcomes?
Background and aims: It is unclear if stroke occurring after cardiac procedures is more severe than stroke associated with cardiac conditions without procedures. We compared in-hospital acute ischemic stroke patients admitted with a cardiac diagnosis who did versus did not undergo cardiac procedures. Methods: In this retrospective cohort study, we analyzed adults with in-hospital stroke admitted with a primary cardiac diagnosis in Alberta (2018–2022). Patients were categorized into no prior cardiac procedure, cardiac procedure, or cardiac surgery within 30 days of stroke diagnosis. Multivariable logistic regression was used to assess associations between exposure groups and outcomes. Results: Among 499 patients (median age 70 years IQR [62–77], 36.7% women), 116 (23.2%) underwent a cardiac procedure, and 227 (45.5%) underwent cardiac surgery prior to stroke diagnosis. Median time from procedure to stroke diagnosis was 1.75 days (IQR 0.87–3.83). In-hospital mortality was 34.6%, 24.1% and 22.5% in patients with no prior procedure, cardiac procedures and cardiac surgery, respectively. After adjustment for age, sex, facility level and comorbidities, no significant differences were observed in mortality (cardiac procedure vs no procedure: aOR 0.73, 95% confidence interval (CI) 0.40–1.33; cardiac surgery vs no procedure: aOR 0.78, 95% CI 0.42–1.45). Among procedural patients, strokes recognized ≥2 days post-procedure were associated with higher mortality (2–7 days: OR 2.31, [1.18–4.52]; 8–30 days: OR 3.23, [1.59–6.59]). Conclusions: Adjusted mortality did not differ by cardiac procedural status, although residual confounding is possible. Later stroke recognition after cardiac procedures was associated with higher mortality, identifying a high-risk monitoring window.
- Open Access
- 24 September 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 655-670
Prevalence, Ocular Manifestations, and Treatment Response in Postbariatric Vitamin A Deficiency: A Systematic Review and Meta-Analysis
- 24 September 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 655-670
Open AccessPrevalence, Ocular Manifestations, and Treatment Response in Postbariatric Vitamin A Deficiency: A Systematic Review and Meta-Analysis
- Open Access
- 25 August 2026
- Published by Elsevier in AJO International
- Vol. 3 (3)
Induced higher-order aberrations following photorefractive keratectomy versus laser-assisted in situ keratomileusis in eyes with high myopia: A systematic review and meta-analysis
- 25 August 2026
- Published by Elsevier in AJO International
- Vol. 3 (3)
Open AccessInduced higher-order aberrations following photorefractive keratectomy versus laser-assisted in situ keratomileusis in eyes with high myopia: A systematic review and meta-analysis
- Open Access
- 7 August 2026
- Published by Elsevier in Ophthalmology Retina
Pharmacologic Interventions for the Prevention and Treatment of Proliferative Vitreoretinopathy
- 7 August 2026
- Published by Elsevier in Ophthalmology Retina
Open AccessPharmacologic Interventions for the Prevention and Treatment of Proliferative Vitreoretinopathy